Recursion to Participate in Upcoming Investor Conferences
Recursion (NASDAQ: RXRX), a clinical stage TechBio company, has announced its upcoming participation in two major investor conferences in May 2025. The company will be presenting at the Bank of America 2025 Health Care Conference on Tuesday, May 13, and the JP Morgan Global Technology, Media and Communications Conference on Thursday, May 15. Interested parties can access the webcasts through Recursion's Investor Relations website at ir.recursion.com.
Recursion (NASDAQ: RXRX), un'azienda TechBio in fase clinica, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel maggio 2025. La societ脿 presenter脿 al Bank of America 2025 Health Care Conference marted矛 13 maggio e al JP Morgan Global Technology, Media and Communications Conference gioved矛 15 maggio. Gli interessati potranno seguire le webcasts sul sito delle Relazioni con gli Investitori di Recursion all'indirizzo ir.recursion.com.
Recursion (NASDAQ: RXRX), una empresa TechBio en etapa cl铆nica, ha anunciado su pr贸xima participaci贸n en dos importantes conferencias para inversores en mayo de 2025. La compa帽铆a presentar谩 en la Bank of America 2025 Health Care Conference el martes 13 de mayo y en la JP Morgan Global Technology, Media and Communications Conference el jueves 15 de mayo. Los interesados podr谩n acceder a las transmisiones web a trav茅s del sitio web de Relaciones con Inversores de Recursion en ir.recursion.com.
Recursion (NASDAQ: RXRX)電� 鞛勳儊 雼硠鞚� TechBio 旮办梾鞙茧, 2025雲� 5鞗� 霊� 臧滌潣 欤检殧 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳棳頃� 鞓堨爼鞛勳潉 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 5鞗� 13鞚� 頇旍殧鞚检棎 鞐措Μ電� Bank of America 2025 Health Care Conference鞕� 5鞗� 15鞚� 氇╈殧鞚检棎 鞐措Μ電� JP Morgan Global Technology, Media and Communications Conference鞐愳劀 氚滍憸頃� 鞓堨爼鞛呺媹雼�. 甏�鞁� 鞛堧姅 攵勲摛鞚� Recursion 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼 ir.recursion.com鞚� 韱淀暣 鞗轨簮鞀ろ姼毳� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
Recursion (NASDAQ : RXRX), une entreprise TechBio en phase clinique, a annonc茅 sa participation prochaine 脿 deux grandes conf茅rences pour investisseurs en mai 2025. La soci茅t茅 pr茅sentera lors de la Bank of America 2025 Health Care Conference le mardi 13 mai, ainsi qu'脿 la JP Morgan Global Technology, Media and Communications Conference le jeudi 15 mai. Les personnes int茅ress茅es pourront acc茅der aux webcasts via le site des Relations Investisseurs de Recursion 脿 l'adresse ir.recursion.com.
Recursion (NASDAQ: RXRX), ein klinisch t盲tiges TechBio-Unternehmen, hat seine bevorstehende Teilnahme an zwei wichtigen Investorenkonferenzen im Mai 2025 angek眉ndigt. Das Unternehmen wird am Bank of America 2025 Health Care Conference am Dienstag, den 13. Mai, sowie am JP Morgan Global Technology, Media and Communications Conference am Donnerstag, den 15. Mai, pr盲sentieren. Interessierte k枚nnen die Webcasts 眉ber die Investor-Relations-Website von Recursion unter ir.recursion.com verfolgen.
- None.
- None.
Salt Lake City, May 06, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:
- Bank of America 2025 Health Care Conference 鈥� Tuesday, May 13, 2025
- JP Morgan Global Technology, Media and Communications Conference 鈥� Thursday, May 15, 2025
Webcasts may be found in the events section of the Recursion Investor Relations website at .听
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world鈥檚 largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale 鈥� up to millions of wet lab experiments weekly 鈥� and massive computational scale 鈥� owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montr茅al, New York, London, Oxford area, and the San Francisco Bay area. Learn more at , or connect on and .
Media Contact
Investor Contact
Ryan Kelly Recursion Pharmaceuticals [email protected]
FAQ
When is Recursion (RXRX) presenting at the Bank of America Healthcare Conference 2025?
What investor conferences is Recursion (RXRX) attending in May 2025?
Where can I watch Recursion's (RXRX) investor conference presentations?
When is Recursion (RXRX) presenting at the JP Morgan Global Technology Conference 2025?
